CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,470,000 | -54.4% | 155,587 | -38.1% | 5.23% | -60.1% |
| Q2 2017 | $7,607,000 | +1449.3% | 251,300 | +645.2% | 13.10% | +1927.9% |
| Q1 2017 | $491,000 | -82.6% | 33,721 | -83.0% | 0.65% | -71.1% |
| Q3 2016 | $2,817,000 | +2745.5% | 198,291 | +400.9% | 2.23% | +2527.1% |
| Q2 2016 | $99,000 | -63.1% | 39,590 | -6.6% | 0.08% | -69.8% |
| Q1 2016 | $268,000 | -37.1% | 42,410 | -38.9% | 0.28% | -10.5% |
| Q4 2015 | $426,000 | – | 69,360 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |